James Shin
Stock Analyst at Deutsche Bank
(1.94)
# 3,050
Out of 4,906 analysts
21
Total ratings
44.44%
Success rate
5.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMTX Immatics | Initiates: Buy | $10 | $5.76 | +73.76% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $109.01 | +10.08% | 2 | Feb 18, 2025 | |
| MRK Merck & Co. | Downgrades: Hold | $128 → $105 | $79.48 | +32.12% | 2 | Feb 18, 2025 | |
| LLY Eli Lilly and Company | Maintains: Buy | $1,025 → $1,015 | $763.25 | +32.98% | 4 | Nov 4, 2024 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $295.22 | +3.31% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $67.42 | -11.01% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $46.78 | -3.79% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $42.44 | +41.38% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $185.99 | -19.35% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $549.63 | +45.55% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.47 | +305.68% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.83 | +1,344.74% | 1 | Nov 9, 2023 |
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $5.76
Upside: +73.76%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $109.01
Upside: +10.08%
Merck & Co.
Feb 18, 2025
Downgrades: Hold
Price Target: $128 → $105
Current: $79.48
Upside: +32.12%
Eli Lilly and Company
Nov 4, 2024
Maintains: Buy
Price Target: $1,025 → $1,015
Current: $763.25
Upside: +32.98%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $295.22
Upside: +3.31%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $67.42
Upside: -11.01%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $46.78
Upside: -3.79%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $42.44
Upside: +41.38%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $185.99
Upside: -19.35%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $549.63
Upside: +45.55%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $2.47
Upside: +305.68%
Nov 9, 2023
Initiates: Buy
Price Target: $12
Current: $0.83
Upside: +1,344.74%